Description: HEXO Corp., through its subsidiary, HEXO Operations Inc., produces, markets, and sells cannabis in Canada. The company offers dried cannabis under the Time of Day and H2 lines; Elixir, a cannabis oil sublingual mist product line; and Decarb, an activated fine-milled cannabis powder product. It provides its products under the HEXO and Hydropothecary brand names. The company serves medical and adult-use markets. The company was formerly known as The Hydropothecary Corporation and changed its name to HEXO Corp. in August 2018. HEXO Corp. is headquartered in Gatineau, Canada.
Home Page: www.hexocorp.com
HEXO Technical Analysis
120 Chemin de la Rive
Gatineau,
QC
J8M 1V2
Canada
Phone:
866 438 8429
Officers
| Name | Title |
|---|---|
| Mr. Mark Attanasio | Exec. Chairman |
| Mr. Charlie Bowman | Pres & CEO |
| Mr. Julius Ivancsits | Chief Financial Officer |
| Mr. Richard Redekop | VP of Cultivation & Operations |
| Jennifer Smith | Mang. of Financial Reporting & Investor Relations |
| Mr. Max Cyr | Director of Customer Experience & Compliance |
| Ms. Joelle Maurais | Gen. Counsel & Corp. Sec. |
| Ms. Isabelle Dominique Robillard | VP of Communication |
| Ms. Sonia Isabel | VP of Sales & Commercial Marketing |
| Mona Matta | VP of People & Culture |
Exchange: NASDAQ
Country: US
Currency: US Dollar ($)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Pharmaceuticals |
| GIC Sub-Industry: | Pharmaceuticals |
| Forward PE: | 4.9044 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 0.4079 |
| Price-to-Sales TTM: | 0.4337 |
| IPO Date: | 2017-03-23 |
| Fiscal Year End: | July |
| Full Time Employees: | 0 |